101 related articles for article (PubMed ID: 22701828)
21. Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients with Type 2 Diabetes: The China Prospective Diabetes Study.
Zang L; Han Y; Chen L; Hu D; Jin H; Yang N; Shi X; Liang L; Liu M; Fan H; Li Q; Mu Y
Diabetes Ther; 2019 Aug; 10(4):1391-1405. PubMed ID: 31222594
[TBL] [Abstract][Full Text] [Related]
22. Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study.
Hassoun AA; Pathan MF; Medlej RC; Alarouj M; Shaltout I; Chawla MS; Knap D; Vaz JA
Diabetes Metab Syndr Obes; 2016; 9():225-31. PubMed ID: 27555791
[TBL] [Abstract][Full Text] [Related]
23. A randomized controlled clinical trial of vildagliptin plus metformin combination therapy in patients with type II diabetes mellitus.
Su Y; Su YL; Lv LF; Wang LM; Li QZ; Zhao ZG
Exp Ther Med; 2014 Apr; 7(4):799-803. PubMed ID: 24669235
[TBL] [Abstract][Full Text] [Related]
24. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
Ferrannini E; Fonseca V; Zinman B; Matthews D; Ahrén B; Byiers S; Shao Q; Dejager S
Diabetes Obes Metab; 2009 Feb; 11(2):157-66. PubMed ID: 19125777
[TBL] [Abstract][Full Text] [Related]
25. RETRACTED: Evaluation of the positive effects on insulin-resistance and β-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients.
Derosa G; Ragonesi PD; Carbone A; Fogari E; D'Angelo A; Cicero AF; Maffioli P
Pharmacol Res; 2013 Jul; 73():20-6. PubMed ID: 23624419
[TBL] [Abstract][Full Text] [Related]
26. Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.
Zografou I; Sampanis C; Gkaliagkousi E; Iliadis F; Papageorgiou A; Doukelis P; Vogiatzis K; Douma S
Hormones (Athens); 2015; 14(1):118-25. PubMed ID: 25402372
[TBL] [Abstract][Full Text] [Related]
27. Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study.
Derosa G; Ragonesi PD; Carbone A; Fogari E; D'Angelo A; Cicero AF; Maffioli P
Expert Opin Pharmacother; 2012 Dec; 13(18):2581-91. PubMed ID: 23121473
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study.
Balaji V
Indian J Endocrinol Metab; 2013 Jul; 17(4):709-15. PubMed ID: 23961491
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of a single-pill combination of vildagliptin and metformin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Odawara M; Yoshiki M; Sano M; Hamada I; Lukashevich V; Kothny W
Diabetes Ther; 2015 Mar; 6(1):17-27. PubMed ID: 25691359
[TBL] [Abstract][Full Text] [Related]
30. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.
Jeon HJ; Oh TK
Diabetes Metab J; 2011 Oct; 35(5):529-35. PubMed ID: 22111045
[TBL] [Abstract][Full Text] [Related]
31. [Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes].
Scheen AJ; Paquot N
Rev Med Liege; 2009 Mar; 64(3):161-7. PubMed ID: 19418936
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study.
Hirose T; Suzuki M; Tsumiyama I
Diabetes Ther; 2015 Dec; 6(4):559-571. PubMed ID: 26620049
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Vildagliptin and Pioglitazone in Korean Patients with Type 2 Diabetes Inadequately Controlled with Metformin.
Kim JH; Kim SS; Baek HS; Lee IK; Chung DJ; Sohn HS; Bae HY; Kim MK; Park JH; Choi YS; Kim YI; Hahm JR; Lee CW; Jo SR; Park MK; Lee KJ; Kim IJ
Diabetes Metab J; 2016 Jun; 40(3):230-9. PubMed ID: 27098505
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
Guarino E; Nigi L; Patti A; Fondelli C; Dotta F
Expert Opin Pharmacother; 2012 Jun; 13(9):1377-84. PubMed ID: 22397507
[TBL] [Abstract][Full Text] [Related]
35. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
[TBL] [Abstract][Full Text] [Related]
36. A 16-week study to compare the effect of vildagliptin versus gliclazide on postprandial lipoprotein concentrations and oxidative stress in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
Hissa MR; Cavalcante LL; Guimarães SB; Hissa MN
Diabetol Metab Syndr; 2015; 7():62. PubMed ID: 26170902
[TBL] [Abstract][Full Text] [Related]
37. Effect of vildagliptin as add-on therapy to a low-dose metformin.
Filozof C; Schwartz S; Foley JE
World J Diabetes; 2010 Mar; 1(1):19-26. PubMed ID: 21537424
[TBL] [Abstract][Full Text] [Related]
38. Metformin and/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: The intriguing effect.
Al-Kuraishy HM; Sami OM; Hussain NR; Al-Gareeb AI
J Adv Pharm Technol Res; 2020; 11(3):142-147. PubMed ID: 33102198
[TBL] [Abstract][Full Text] [Related]
39. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
[TBL] [Abstract][Full Text] [Related]
40. Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study.
Chen Y; Li Q; Han Y; Ji H; Gu M; Bian R; Ding W; Cheng J; Mu Y
Diabetes Ther; 2020 Jan; 11(1):247-257. PubMed ID: 31823167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]